About
Peptron develops sustained release injectable drug formulations using its proprietary ultrasonic spray drying technology, focusing on long-acting medications including treatments for neurodegenerative disorders such as exenatide.
Explore Peptron's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.